HLS Therapeutics is a startup based in Unknown, most recent round IPO, 1 tracked investor.
HLS Therapeutics is a company headquartered in Unknown. Its most recent tracked round is IPO. Brouky records 1 investor associated with the company.
HLS Therapeutics is a specialty pharmaceutical company that manages a portfolio of commercial-stage branded medicines (e.g., clozapine and icosapent ethyl). The company sources products from originators and manufacturing partners and focuses on regulatory compliance and reliable market access in North America.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.